SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Manshouri, T. Articles by Albitar, M. Search for Related Content PubMed PubMed Citation Articles by Manshouri, T. Articles by Albitar, M. Related Collections Neoplasia Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, Vol. 89 No. 7 (April 1), 1997: pp. 2507-2515 Downregulation of RAR in Mice by Antisense Transgene Leads to a Compensatory Increase in RAR and RAR and Development of Lymphoma By Taghi Manshouri, Yun Yang, Huai Lin, Sanford A. Stass, Armand B. Glassman, Michael J. Keating, and Maher Albitar From the Divisions of Laboratory Medicine and Medicine, The University of Texas M.D. Anderson Cancer Center, Houston.     ABSTRACT Abstract Introduction Methods Results Discussion References Retinoic acid receptors (RARs) , , and contain retinoic acid response elements (RAREs) in their promoter regions and respond to their own activation, thus forming an autoregulatory loop. We generated transgenic mice that expressed an antisense construct of the RAR. Homozygous transgenic mice demonstrated 30% to 80% reduction in RAR protein expression in various tissues. Unlike RAR null mice generated by knockout, our antisense mice demonstrated significant compensatory increases in the expression of RAR and RAR proteins. Coarse fur, male sterility, and low body weight were other abnormalities observed in these mice. Most importantly, lymphoma developed in 44% of our homozygous transgenic mice at an early stage of life. These data suggest that RAR is necessary for appropriate response of the RAR and RAR genes to physiologic changes and deregulation of the RAR in transgenic mice, which resulted in upregulation of RAR and RAR, can be associated with lymphomagenesis. Thus, the data support the hypothesis that a balance among the RARs is necessary for appropriate response to various homeostatic needs.     INTRODUCTION Abstract Introduction Methods Results Discussion References THE VITAMIN A-DERIVED hormones and their natural and synthetic analogues (retinoids) affect a large number of biological processes, including growth, differentiation, morphogenesis, metamorphosis, development, vision, immunity, and fertility.1-6 Retinoids have also shown promise in the treatment and prevention of various tumors.1,3,4 The effects of retinoids are believed to be mediated by two families of receptors, retinoic acid receptors (RARs) and retinoid X receptors (RXRs).3 The RAR family includes RAR, RAR, and RAR, which bind all-trans-retinoic acid and to 9-cis-retinoic acid with high affinity.3,7 The RXR family includes RXR, RXR, and RXR, which specifically binds to 9-cis-retinoic.3,8 These two families belong to the steroid/thyroid hormone receptor superfamily, which is a family of ligand-induced transcription-regulation factors. RARs form homodimers or heterodimers with RXRs to bind specifically to DNA sequences.9 Each of the RARs is expressed in distinct patterns throughout development and in the mature organism.3,10 Furthermore, genes encoding these receptors show greater conservation between species than between each other.4,11 These observations suggest that various RARs mediate different functions. The targets of the retinoid-activated receptors are highly regulated genes. These genes contain specific DNA sequences called retinoic acid response elements (RAREs) that contain direct repeats (AGGTCA) separated by 3, 4, or 5 nucleotides.3,4,10,12,13 Interestingly, RARs themselves contain RAREs in their promoters and respond to RAR-mediated activation forming an autoregulatory loop. The effects of the retinoids may be amplified through the upregulation of RARs in this autoregulatory loop, so that small increases in retinoids may result in disproportionately greater biologic changes. It is believed that the remarkable difference in differentiation seen in the developing limb bud upon minimal difference in the concentration of retinoic acid is the result of this functional amplification.3,4,14 Complete abolition of the expression of the RAR gene in mice by homologous recombination and "knockout" leads to changes similar to those seen in mice fed a vitamin A-deficient diet.11 Approximately 90% of RAR null mice die before the age of 2 months. This indicates that RAR plays a role in the maintenance of some homeostatic processes. These RAR null mice do not demonstrate compensatory increases in the expression of RAR or RAR.11 Both RAR and RAR contain RARE in their promoter regions, and the complete absence of RAR protein in these null mice may alter their ability to respond to physiologic alterations. To investigate the effects of a significant change in (but not the complete absence of ) RAR expression on various homeostatic processes, we generated transgenic mice expressing an antisense RAR gene. Expression of antisense RAR in these transgenic mice leads to 30% to 80% reduction in the level of RAR protein in various tissues. Interestingly, these antisense transgenic mice showed compensatory increases in the RAR and RAR proteins. These mice were characterized by coarse fur, low body weight, and male sterility, and lymphoma developed in 44% of these mice. These data expand our understanding of the regulatory function of RAR and suggest that RAR deregulation may be involved in lymphomagenesis.     MATERIALS AND METHODS Abstract Introduction Methods Results Discussion References Generation of transgenic mice. We inserted the human RAR cDNA in the sense and antisense orientation at the Sal I site of the expression vector pMAMneo (CLONTECH, Palo Alto, CA) using an appropriate linker. This expression vector contains the RSV/MMTV-LTR (Rous sarcoma virus/mouse mammary tumor virus-long terminal repeat) promoter/enhancer and SV40 splicing/polyadenylation sites. The inserted human RAR cDNA is 3 kb in length and is highly homologous to the mouse RAR cDNA. The DNA construct was isolated from the bacterial sequence by digestion with EcoRI and Pvu I and microinjected into fertilized mouse eggs as previously described.15 Briefly, DNA was microinjected into the male pronucleus of fertilized F1 hybrid eggs from SWRxSJL mice. The injected eggs were incubated in Whittens medium at 37°C and transferred into the oviduct of a CD-1 pseudopregnant foster mother. Generated mice were first screened using the polymerase chain reaction (PCR), then confirmed by Southern blot analysis. Six independent transgenic lines were generated carrying the antisense construct and four lines were generated carrying the sense RAR construct. These mice were intercrossed and intracrossed to generate homozygous mice. DNA isolation and analysis. Genomic DNA was prepared from the tails and lymphoma tissues of the transgenic mice. Transgenic mice were screened by PCR analysis. The 3' primer (5'-GATGCTGCGGCGGAAGAAGCCCTT-3') corresponds to RAR and the 5' primer (5'-ACTCACCATAGGGACCAAGCT-3') corresponds to MMTV. The amplified fragment was approximately 469 bp and was resolved on denaturing polyacrylamide gel as previously described.15 PCR-positive transgenic mice were confirmed by Southern blot analysis. When the intensity of the transgene band was compared with that of the mouse -globin band seen by PCR, we estimated the transgene copies to be 2, 4, and 8 in three lines that were further studied. DNA was digested with BamHI and Sal I, electrophoresed through a 0.8% agarose gel, blotted onto a nitrocellulose membrane, and probed with a 32P-labeled 0.5 Kb Pst I fragment of the human RAR cDNA. Southern blotting was performed as previously described.16 As expected, we detected a 2.1-kb fragment upon digestion with BamHI and Sal I. Digestion with BamHI showed a relatively strong 3.5-kb fragment that is expected to span two adjacent fragments of the transgene, which suggests that the transgenes are integrated in a tandem repeat (head to tail) fashion. Considering the low copy number of transgenes 2, 4, and 8, it is most likely that the integration of transgenes was in a single site. Homozygous mice were determined based on the intensity of the transgene bands using densitometric analyses. Genomic DNA from lymphoma samples was digested with EcoRI, BamHI, and HindIII and analyzed by Southern blot analysis using the 1-kb Xba I-EcoRI mouse Ig JH3-4 heavy-chain genomic probe.17 RNA isolation and analysis. Total RNA was extracted from various tissues of transgenic mice by the guanidine hydrochloride method as previously described.18 RAR antisense mRNA expression was detected using reverse transcription (RT)-PCR using the following two primers: 5'-TGTGTCGGCCCATCTACTGTC-3' and 5'-GAGTTTTCCCAGACCTGGCTC-3'. Expression of the RAR transgene was detected using the following two primers: 5'-TGAAGCCCACCAGAGCCCCCT-3' and 5'-GATGCTGCGGCGGAAGAAGCC-3'. The 3' primer of this set is a unique primer that amplifies only the human mRNA transgene. Expression of the endogenous mouse RAR gene was detected using the following primers: 5'-CAAGACAAATCATCCGGCTAC-3' for the 5' primer and 5'-GTACTTGCCCAGCTGGCAGAG-3' for the 3' primer in the PCR and RT. The amplification product was 338 bp. The following primers were used for RT/PCR of the mouse -actin: 5'-CCATCCTGCGTCTGGACCTGGCTG-3' and 5'-GCTCGTTGCCAATAGTGATGACCT-3'. These primers amplify a 240-bp fragment of -actin mRNA. RT was performed using the 3' primers. PCR was performed using the following cycling conditions: denaturation at 95°C for 5 minutes, followed by 30 cycles of 58°C for 30 seconds, 74°C for 2 minutes, and 94°C for 1 minute. In each PCR reaction, one of the two primers of each set was end-labeled with [-32P] adenosine triphosphate (ATP) in the presence of T4 polynucleotide kinase. The amplification products were resolved on denaturing polyacrylamide gels as previously described.15 Coamplification of -actin and RAR was used as a semiquantitative assay to compare the expression of RAR in hemizygous mice with that in homozygous transgenic mice. The coamplification was always performed side by side with the amplification of RAR alone and -actin alone and the coamplification was accepted when the intensity of the bands in the coamplification tube was comparable to that seen in the tubes with RAR alone and -actin alone. The linearity of such an assay in the condition described here was previously reported.15 Protein isolation and analysis. Fresh tissue from various organs of normal and transgenic mice was homogenized in ice-cold buffer (20 mmol/L Tris/HCL, PH 7.2, 1 mmol/L EDTA, 1 mmol/L EGTA, 0.1 mol/L NaCl, 1 mmol/L phenylmethyl sulfonyl fluoride [PMSF ], 0.1% aprotinin, 0.1% leupeptin, 0.1% pepstatin, and 0.1% Triton 100 X). After solubilization on ice for 1 hour, the lysate was centrifuged at 35,000 rpm for 45 minutes, and the supernatant was collected. The protein concentration was estimated by BioRad (Hercules, CA) standard assay, and 200 mg of each extract was run on a 9.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel and stained with Coomassie blue R-250 to check the protein profile. After necessary adjustment for protein concentration was made, 200 mg of protein extract was electrophoresed on a 9.5% SDS-PAGE gel and transferred to nitrocellulose membrane. The nitrocellulose membrane was blocked with 5% nonfat milk in phosphate-buffered saline (PBS) solution containing 0.1% Tween 20 for 6 hours at room temperature. The blot was then incubated with 1 µg/mL of mouse monoclonal anti-RAR antibody (IgG1, MA1-810), RAR antibody (IgG2a, MA1-811) (both from Affinity Bioreagents, Neshanic Station, NJ), and RAR (a generous gift from Dr P. Chambon, Strasbourg Cedex, France), in 5% bovine serum albumin overnight at 4°C. After washing with PBS containing 0.1% Tween 20, the membrane was incubated with sheep antimouse-horseradish peroxidase (HRP)-IgG conjugate for 2 hours at room temperature. Immunoblots were then washed, and immunoreactive bands were visualized with an enhanced chemilluminescence detection system according to the manufacturer's instructions (Amersham, Arlington Heights, IL). The autoradiographs were scanned, and bands were quantified using Scan Analysis software from Biosoft (Cambridge, UK) and a Macintosh-based scanner and computer (Cupertino, CA). Some membranes were stripped and reprobed with another antibody using the procedures recommended by the manufacturer (Amersham, Arlington Heights, IL). To block nonspecific binding of the secondary antibody (sheep antimouse IgG), membrane was first blocked with nonfat milk then incubated with sheep antimouse IgG for 2 hours at room temperature before incubation with the RAR and RAR antibodies. This step was adequate to block the nonspecific high molecular bands seen on some blots. Tissue sections. Tissues for light microscopy were fixed in 10% neutral buffered formalin and processed for paraffin embedding. The sections were stained with hematoxylin and eosin.     RESULTS Abstract Introduction Methods Results Discussion References Generation of transgenic mice expressing an RAR sense and antisense gene. In one set of experiments, we microinjected into mouse oocytes a human sense RAR DNA construct and in a second set of experiments, we injected the antisense RAR DNA construct. The human 3-kb full-length RAR cDNA was inserted in sense and antisense orientation downstream of the RSV/MMTV-LTR promoter/enhancer. Four founder transgenic lines expressing sense RAR were generated from the first set of experiments, and expression of sense RAR mRNA was detected using RT/PCR (data not shown). No phenotypic abnormality was observed in hemizygous or homozygous sense RAR mice. Six founder transgenic lines carrying the antisense construct were generated from the second set of experiments. Five of the six founders expressed RAR antisense mRNA as detected by RT/PCR (data not shown). Only three of the five lines designated here as lines 1, 2, and 3, were analyzed further. None of the hemizygous antisense RAR mice displayed phenotypical abnormality despite a variation in the copy number of the transgene (2, 4, and 8 copies). However, homozygous antisense transgenic mice of the three lines displayed a distinct phenotype (Fig 1). All homozygous mice demonstrated coarse fur and low body weight. We compared 20 randomly selected transgenic mice with 20 littermates and found that homozygous transgenic mice weighed an average of 15% to 20% less than their normal or transgenic heterozygous littermates at 4 weeks of age. The transgenic mice remained smaller throughout their lives and demonstrated coarse fur (Fig 1). Homozygous mice obtained by intercrossing line 1 and line 2 showed a similar phenotype. None of the transgenic homozygous male mice was fertile because, although they were constantly caged with females, they failed to sire litters. View larger version (116K): [in this window] [in a new window]   Fig 1. Appearance of RAR antisense mice. Homozygous RAR antisense transgenic mice are smaller and have coarse fur; back, transgenic mouse; front, normal littermate. Reduction of expression of RAR mRNA and protein in antisense transgenic mice. Total RNAs from various tissues from normal littermate controls, transgenic hemizygous mice, and homozygous mice from three transgenic lines were analyzed for the level of expression of RAR mRNA by RT/PCR. The level of RAR mRNA was compared with -actin mRNA in three transgenic lines. In each amplification, one of the primers of each set was 32P-end-labeled so that the cDNA products could be directly visualized by autoradiography. As shown in Fig 2, significant reduction in the RAR amplification product as compared with the -actin amplification product is noted in hemizygous and homozygous transgenic mice from the three lines. View larger version (21K): [in this window] [in a new window]   Fig 2. Comparison of RAR and -actin mRNA levels in normal (-/-), hemizygous transgenic (T/-), and homozygous transgenic (T/T) mice in three transgenic lines. Representative RT-PCR coamplification of RAR and -actin mRNAs in kidneys. Although RT/PCR assay is not quantitative, more reduction in RAR mRNA is seen in homozygous mice as compared with hemizygous mice. Figure 2 shows the level of RAR mRNA reduction in kidney tissue samples. Similar levels of reduction were noted in most tissue samples that were examined. The level of expression of RAR protein in homozygous antisense transgenic mice was examined using immunoblot analysis. In Fig 3, we compared the RAR protein levels in the skin, lung, testis, spleen, liver, and kidney of homozygous and hemizygous transgenic mice with those in the same tissues of normal littermate mice resulting from intercrossing line 1 hemizygous mice. The Western blot analysis demonstrated striking reductions in the levels of RAR protein in the various tissues of the homozygous transgenic mice and a lesser degree in those of hemizygous mice (Fig 3). Figure 4A is representative Western blot analysis showing changes in RAR protein expression in homozygous transgenic mice generated from intercrossing line 2 hemizygous mice. The most striking reduction (almost complete absence or 40% to 85% reduction, as determined by densitometer) in RAR protein level was observed in lung, testis, liver, and kidney tissues. No significant variation was observed between line 2 and line 3. Equal loading of protein from transgenic and normal mice was confirmed by staining filters with amido black stain. A similar pattern of reduction of expression was detected in homozygous transgenic mice resulting from interline crossing. View larger version (21K): [in this window] [in a new window]   Fig 3. Comparison of RAR protein in normal (-/-), hemizygous transgenic (T/-), and homozygous transgenic (T/T) mice generated from line 1 in various tissues. The Western blot analysis shows marked reduction in RAR in homozygous mice and less reduction in RAR in hemizygous mice. View larger version (27K): [in this window] [in a new window]   Fig 4. Reduction of RAR protein by the RAR antisense construct and compensatory increase in the RAR and RAR proteins. Western blot analysis of protein isolated from normal control (N) mice and transgenic (T) mice (line 2) from the indicated organs. Equal amounts of protein were resolved on SDS-PAGE, transferred to nitrocellulose membrane, and probed with specific RAR (A), RAR (B), and RAR (C) antisera as indicated. The percentage of RAR reduction in each tissue is indicated in (A) and the levels of increase in RAR and RAR proteins are shown in (B and C). Compensatory increase in the RAR and RAR proteins. To test whether there was a compensatory increase in the expression of RAR or RAR in the homozygous mice, we compared the levels of expression of RAR and RAR in various tissues of the transgenic mice and normal control mice (Fig 4). We used Western blot analysis and monoclonal antibodies to study RAR and RAR levels. There was significant compensatory (threefold in some tissues) increase in the levels of RAR and RAR in most tissues examined (lung, testis, spleen, liver, brain, and kidney). Figure 4 shows representative Western blots showing tissues from line 2. Using a densitometer, we detected a twofold increase in the RAR in lung and a 3.1-fold increase in liver (Fig 4). We detected similar levels of increase in RAR in lung, testis, and kidney (Fig 4). Equal loading of protein from transgenic and normal mice was confirmed by staining filters with amido black stain. In some experiments, the Western blot filters were stripped and reprobed with antibodies for RAR, and the inverse relationship between RAR protein levels and RAR and RAR (data not shown) protein levels was confirmed. This contrasts with the previously reported lack of compensatory increase in RAR mRNA in RAR null mice. Glandular atrophy and squamous metaplasia. The transgenic mice had coarse fur (see Fig 1). Microscopic examination of skin sections showed significant atrophy in sebaceous glands and hair follicles (Fig 5A and B). Empty hair follicles and no inflammatory response in the dermis represented the most striking histologic abnormality in the skin. In addition to the atrophy in the hair follicles and the surrounding sebaceous gland, a thick, fibrous sheath was noted in the dermis. View larger version (120K): [in this window] [in a new window]   Fig 5. Histologic changes in the RAR antisense mice as compared with normal littermates. Sections of skin of normal (A) and transgenic (B) mice showing significant atrophy and degeneration in pilosebaceous units (arrowhead) in transgenic mice (B) as compared with normal mice (A). (C) and (D) are sections from normal and transgenic mice, respectively. Poor order of spermatogenesis (arrow) and few spermatozoa are seen in the seminiferous tubules of transgenic mice as compared with those of normal mice. Sections of epididymides of normal (E) and transgenic (F ) mice show marked squamous metaplasia (arrow) in transgenic mice, but pseudostratified epithelium in normal mice (arrow). Microscopic and gross examination of the vas deferens of infertile homozygous male mice showed no obvious obstruction. Histologic examination of the testes of homozygous transgenic mice showed some atrophy in some of the seminiferous tubules (Fig 5D). Some seminiferous tubules demonstrated morphologic changes similar to those described in incomplete spermatocytic arrest syndrome.19 Normal maturation of spermatogonia into spermatozoa seems to be progressing in poor order as shown in Fig 5D. Spermatogenic cells in normal mice differentiate progressively from the basal region of the tubule to the lumen (Fig 5C). In contrast, in transgenic mice, immature germ cells can be seen in the lumen and more differential cells (small with abundant cytoplasm) are seen in the basal area (Fig 5D). The tubules were slightly reduced in diameter. The majority of the tubules contained sloughed spermatogenic cells. The sloughed cells consisted primarily of spermatocytes admixed with mature elements. Based on examining seminiferous tubules of 4 different transgenic mice (1 mouse from line 1, 2 from line 2, and 1 from line 3), it appears that more than 50% of seminiferous tubules were affected. Rare tubules were surrounded by mild fibrosis (one or two in each histologic section). Sertoli and Leydig cells appeared normal. Focal squamous metaplasia was observed in the epididymides (Fig 5F ) and the prostate and bulbourethral glands of some male mice. Lymphoma development in transgenic mice. The most important abnormality we observed in these antisense homozygous transgenic mice was the development of tumors in a significant number of mice at an early stage of life. As shown in Table 1, most tumors were lymphomas. Lymphomas developed in 15 (44%) of the 34 surviving homozygous mice, and sweat gland tumors developed in two mice. Most of the lymphomas formed in the abdomen (Fig 6A). However, one lymphoma developed in an orbital cavity, and three were found in the thymus (Fig 6B). One lymphoma developed in the axilla. Histologically, most lymphomas appeared to be of low-grade and of small cell type (Fig 6C and F ). Some lymphomas (thymus, orbital, and axillary) showed aggressive high-grade morphology with larger cells and more open chromatin (Fig 6D). Most lymphomas were of B-cell lineage as determined by restriction of immunoglobulin genes (Fig 7). Furthermore, IgG gene rearrangement study demonstrates clonality of the tumors and confirms that these tumors are malignant and not a benign lymphoid hyperplasia. One case of lymphoma involving the thymus was Thy-1.2 and CD-3 positive and showed no evidence of immunoglobulin gene rearrangement (Fig 7). Lymphoma developed in two heterozygous founders of the transgenic mice at a late stage of life.   View this table: [in this window] [in a new window]   Table 1. Tumor Formation in RAR Antisense Mice View larger version (76K): [in this window] [in a new window]   Fig 6. Development of lymphoma in transgenic mice. (A) and (B) depict the gross appearance of malignant lymphomas developed in transgenic mice. In (A), the tumor (T) was abdominal and compressed, but did not invade the intestines (I). In (B), the tumor (T) involved the thymus and invaded lungs (L) and heart (H). (C) and (D) show representative histologic sections of the tumors shown in (A) and (B), respectively. Diffuse small lymphocytic (low-grade) lymphoma is seen in the abdominal tumor, and a more aggressive lymphoma with open chromatin (lymphoblastic-like) is seen in the thymus tumor. (E) Shows lymphoma invading skeletal muscles. (F ) Shows another pattern of lymphoma observed in abdominal tumors with small cells and condensed chromatin. View larger version (74K): [in this window] [in a new window]   Fig 7. Clonality of the lymphoid tumors as demonstrated by immunoglobulin gene rearrangement studies. Southern blot analysis of some lymphoid tumors showing immunoglobulin gene rearrangement. Three different lymphomas (labeled 1-3) were digested with EcoRI and HindIII as indicated. C, control liver DNA from one of the mice; T, DNA from a T-cell lymphoma showing no rearrangement for the immunoglobulin gene. Germline band is indicated by a dash on the side.     DISCUSSION Abstract Introduction Methods Results Discussion References There are few examples of the use of antisense DNA constructs in transgenic animals.20-24 Pepin et al23 used an antisense DNA construct to partially knock out the expression of the type II glucocorticoid receptor in transgenic mice and demonstrated significant reduction (50% to 70%) in the expression of the receptor mRNA. The guanosine triphosphate-binding regulatory protein (Gai2 ) was partially knocked out (<5% Gai2 protein in some tissues) in transgenic mice using a construct containing only 39 bp of the Gai2 gene upstream of the phosphoenolpyruvate carboxykinase (PEPCK) gene.25 In the study reported here, we focused on producing transgenic mice that expressed antisense RAR mRNA. We found that the expression of this antisense RAR mRNA led to partial knockout of RAR mRNA and protein expression in hemizygous and homozygous transgenic mice (Figs 2 and 3). Hemizygous mice did not demonstrate any phenotypic abnormality despite the reduction in RAR expression. In contrast, mice that contain a similar construct, but express the sense RAR, do not show any abnormality. Based on Western blot analysis (Figs 3 and 4), we demonstrated significant reduction in the level of RAR protein (30% to 80%) in various tissues in homozygous mice and to a lesser degree in hemizygous mice. Although the level of the RAR protein was low, it could still be detected in all tissues. Unlike the complete knockout of the expression of RAR gene in RAR null mice,11 the low level of expression of the RAR led to a compensatory increase in the expression of RAR and RAR proteins (Fig 4). The mechanism of this compensatory increase in RAR and is not clear. RARs are involved in regulating numerous genes and they are regulated by several genes. However, it is possible that the autoregulatory function of the RARs is contributing to this compensatory increase of RAR and RAR proteins. It is possible that the remaining RAR protein binds along with other factors to the RARE in the promoters of the RARs and leads to this compensatory increase in RAR and RAR, and this may explain the lack of any compensatory increase in RAR and RAR in the complete RAR knockout mice. Therefore, it seems that a low level of RAR is necessary for the appropriate response of RAR and RAR. This raises the possibility that in RAR null mice, the function of the RAR and RAR is actually impaired because of the complete lack of RAR expression. Despite variation in the copy number (approximately 2, 4, and 8) of the antisense transgene in various lines, the levels of RAR downregulation were similar; this may reflect that the expression of the transgene is not copy number-dependent. This is consistent with previous reports by several investigators indicating that transgenes are expressed in transgenic mice in copy number-independent fashion unless they are linked to a locus control region, which provides open chromatin structure and confers copy number-dependent expression.26 It is speculated that this is because usually all copies of the transgene are integrated in a head-to-tail fashion in a single site in the genome, and not all copies are expressed. Significant increase of expression in homozygous mice usually is because the expression in homozygous is generated from two independent sites on two chromosomes. Major characteristics of the homozygous transgenic mice were their coarse fur and low body weight (Fig 1). All homozygous transgenic mice weighed approximately 15% to 20% less at 4 weeks of age than their normal littermates and remained smaller throughout their lives. Histologic examination of sections of the skin showed some focal atrophy in sebaceous and sweat glands (Fig 5B). The males were infertile. The testicles were normal in size, and normal-appearing spermatozoa were seen in the lumina of the seminiferous tubules. However, in the homozygous mice most of the seminiferous tubules were smaller in diameter than those in the normal mice and showed some irregularity in the maturation of the spermatozoa and sloughing of cells (Fig 5D). Sperm was seen in the vas deferens. Focal squamous metaplasia was observed in the epididymides and prostates of some mice (Fig 5). Abnormal maturation of spermatozoa and disorganized order of maturation has been reported to be a cause for infertility in humans.19 In our antisense transgenic mice, it is possible that this abnormal maturation combined with some degeneration in the glandular tissue of the genital system (prostate, bulbouretheral gland, etc) leads to infertility. RAR null mice show more severe degeneration in the germinal epithelium of the seminiferous tubule.11 This may reflect the severity of the reduction in the RAR expression and perhaps the compensatory increase in the expression of RAR and RAR. More severe degeneration in the glandular tissues in the skin and genitourethral system, as well as emaciation and a slower rate of growth, has been reported in animals fed a vitamin A-deficient diet. The changes seen in our transgenic mice indicate that RAR is important in the overall maintenance of general homeostatic processes, including the regulation of RAR and RAR. This is consistent with the ubiquitous expression reported for the RAR.4 These transgenic mice represent an excellent model system in which to investigate the role of the RAR on the activation and function of other hormone receptors that are known to interact with RAR. These include the RXRs, steroid hormone receptors, peroxisome proliferator-activated receptor, vitamin D3 receptor, and thyroid hormone receptor. As shown in Table 1, 44% of the homozygous transgenic mice developed lymphoma at an early stage of life. On the basis of morphology, most of these were low-grade lymphomas (Fig 6). However, aggressive subtypes of lymphoma (Burkitt's-type or lymphoblastic) were also noted in some mice. Most of these lymphomas were B-cell lymphomas. The clonality of these tumors was confirmed by Ig gene rearrangement study (Fig 7). Retinoids are known to have significant effects on the immune system in general and on the proliferation and differentiation27-30 of lymphoid cells, but a direct relationship between RAR and lymphomagenesis has not been previously reported. Overexpression of RAR in T lymphocytes in transgenic mice leads to a significant increase in the CD-8+ T cells in these mice.29 Treatment of some Burkitt's lymphoma cell lines with all-trans-retinoic acid results in a dose-dependent decrease in the growth rate.31 In addition, retinoids are considered potent chemopreventive agents against tumors involving many organs, including the breast, skin, lung, prostate, pancreas, liver, digestive tract, and oral cavity.4 Animals deficient in vitamin A are more susceptible to cancer.4 Administration of retinoids can also reverse malignant epithelial changes.4 This chemopreventive function of retinoids is believed to work through their regulation of cell proliferation and differentiation.4 From our data, it is difficult to determine the direct cause of lymphomagenesis in these mice because RARs are involved in regulating the expression of many genes. Lymphoma development in RAR null mice was not reported.11 Whether this apparent discrepancy between our mice and null mice is caused by the difference in the genetic background of the mice used in both experiments or caused by the physiologic difference (partial v complete knockout) is currently unknown. The compensatory increase in RAR and RAR in our mice may be a factor in this discrepancy. Furthermore, additional differences in other nuclear proteins such as RXRs that were triggered by the low level expression of RAR may also explain some of these discrepancies. The possibility that the RAR antisense independently of the RAR is interfering with other processes cannot be ruled out, but appears unlikely because transgenic mice carrying the sense construct do not show phenotypic abnormality. The transcription of RAR and RAR are perhaps the most homologous transcripts to RAR and do not appear to decrease. Our data from transgenic mice clearly demonstrate that changes in RAR expression can be associated with several phenotypic abnormalities and lymphomagenesis in mice.     FOOTNOTES    Submitted July 23, 1996; accepted November 6, 1996.    M.A. is a recipient of the Physician Scientist Award from the National Institutes of Health, Bethesda, MD, Grant No. HL-02229. Animal work is supported in part by M.D. Anderson Cancer Center CORE grant from the National Cancer Institute, Grant No. CA-16672.    Address reprint requests to Maher Albitar, MD, Hematopathology Program, Division of Laboratory Medicine, Box 72, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4095.    The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hearly marked ``advertisment'' in accordance with 18 U.S.C. section 1734 solely to indicate this fact.     ACKNOWLEDGMENT We thank Dr R. M. Evans of The Salk Institute for providing the human RAR cDNA, Dr T. McDonnell of The University of Texas M.D. Anderson Cancer Center for providing the mouse immunoglobulin JH3-4 heavy chain genomic probes, and Dr P. Chambon of Strasbourg, France, for providing RAR antibodies.     REFERENCES Abstract Introduction Methods Results Discussion References 1. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 240:889, 1988[Abstract/Free Full Text] 2. Kastner P, Leid M, Chambon P: The role of nuclear retinoic acid receptors in the regulation of gene expression, in Blomhoff R (ed): Vitamin A in Health and Disease. New York, NY, Marcel Dekker, 1993, p 189 3. Livrea MA, Packer L: Retinoids. New York, NY, Marcel Dekker, 1993, p 319 4. Sporn MB, Roberts AB, Goodman DS: The Retinoids (vols 1 and 2). New York, NY, Raven, 1994 5. Underwood JN: Vitamin A in animal and human nutrition, in Sporn MB, Roberts AB Goodman DS (eds): The Retinoids (vol 1). Orlando, FL, Academic, 1984, p 282 6. Wilson JG, Roth CB, Warkany J: An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 92:189, 1953[Medline] [Order article via Infotrieve] 7. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: The second decade. Cell 83:835, 1995[Medline] [Order article via Infotrieve] 8. Mendelsohn C, Ruberte E, LeMeur M, Morriss-Kay G, Chambon P: Developmental analysis of the retinoic acid-inducible RAR-2 promoter in transgenic animals. Development 113:723, 1991[Abstract] 9. Green S: Promiscuous liaisons. Nature 361:590, 1993[Medline] [Order article via Infotrieve] 10. Dolle P, Ruberte E, Kastner P, Petkovich M, Stoner CM, Gudas LJ, Chambon P: Differential expression of genes encoding , , and retinoic acid receptors and CRABP in the developing limbs of the mouse. Nature 342:702, 1989[Medline] [Order article via Infotrieve] 11. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, Le Meur M, Chambon P: High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci USA, 90:7225, 1993 12. Naar AM, Boutin JM, Lipkin S, Yu VC, Holloway JM, Glass CK, Rosenfeld MG: The orientation and spacing of core DNA-binding motifs dictate selective transcriptional response to three nuclear receptors. Cell 65:1267, 1991[Medline] [Order article via Infotrieve] 13. Umesono K, Evans RM: Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 65:1255, 1989 14. Mohanty-Hejmadi P, Dutta SK, Mahapatra P: Limbs generated at the site of tail amputation in marbled balloon frog after vitamin A treatment. Nature 355:352, 1992[Medline] [Order article via Infotrieve] 15. Albitar M, Katsumata M, Liebhaber SA: Human a-globin genes demonstrate autonomous developmental regulation in transgenic mice. Mol Cell Bio, 11:3786, 1991 16. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989 17. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaege U, McKearn JP, Korsmeyer SJ: bcl-2 Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989[Medline] [Order article via Infotrieve] 18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156, 1987[Medline] [Order article via Infotrieve] 19. Rosai J: Surgical Pathology (ed 7). Washington, D.C., Mosby, 1989 20. Imoto S, Miki N, Hatano M, Aizawa S, Tokuhisa T: Regulation of class II MHC gene expression by the inducible anti-sense RNA in transgenic mice. Anal Biochem 210:231, 1993[Medline] [Order article via Infotrieve] 21. Khillan JS, Li SW, Prockop DJ: Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene. Proc Natl Acad Sci USA 91:6298, 1994[Abstract/Free Full Text] 22. Miki N, Tokuhisa T: Inhibition of class II MHC gene expression by anti-sense RNA in transgenic mice. Biochem Biophys Res Commun 186:832, 1992[Medline] [Order article via Infotrieve] 23. Pepin M-C, Pothier F, Barden N: Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725, 1992[Medline] [Order article via Infotrieve] 24. Richard D, Chapdelaine S, Deshaies Y, Pepin MC, Barden N: Energy balance and lipid metabolism in transgenic mice bearing an antisense GCR gene construct. Am J Physiol 265:146, 1993 25. Moxham CM, Hod Y, Malbon CC: Induction of Gi2 -specific antisense RNA in vivo inhibits neonatal growth. Science 260:991, 1993[Abstract/Free Full Text] 26. Grosveld F, Antoniou M, Berry M, deBoer E, Dillon N, Ellis J, Fraser P, Hanscombe O, Hurst J, Imam A, Lindenbaum M, Philipen S, Pruzina S, Strouboulis J, Raguz-Bolognesi S, Talbot D: The regulation of human globin gene switching. Phil Trans Roy Soc Lond B Biol Sci B339:183, 1993 27. Cheng AL, Su IJ, Chen CC, Tien HF, Lay JD, Chen BR, Pu YS, Hong RL, Shen MC, Wang CH: Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study. J Clin Oncol 12:1185, 1994[Abstract/Free Full Text] 28. Chow JM, Cheng AL, Su IJ, Wang CH: CH13-cis-retinoic acid induces cellular differentiation and durable remission in refractory cutaneous Ki-1 lymphoma. Cancer 67:2490, 1991[Medline] [Order article via Infotrieve] 29. Pohl J, La Face D, Sands JF: Transcription of retinoic acid receptor genes in transgenic mice increases CD8 T-cell subset. Mol Biol Rep 17:135, 1993[Medline] [Order article via Infotrieve] 30. Sasaki N, Hayashi M, Aoyama S, Yamashita T, Miyoshi I, Kasai N, Namioka S: Transgenic mice with antisense RNA against the nucleocapsid protein mRNA of mouse hepatitis virus. J Vet Med Sci 55:549, 1993[Medline] [Order article via Infotrieve] 31. Faulkner L, Katz DR, Brickell PM: Retinoic acid induces changes in c-fgr proto-oncogene mRNA levels in Burkitt's lymphoma cells. Immunobiology 188:460, 1993[Medline] [Order article via Infotrieve] © 1997 by The American Society of Hematology. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: Z. Gang Wang, L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, and P. Paolo Pandolfi Role of PML in Cell Growth and the Retinoic Acid Pathway Science, March 6, 1998; 279(5356): 1547 - 1551. [Abstract] [Full Text] K. Mehta, T. McQueen, T. Manshouri, M. Andreeff, S. Collins, and M. Albitar Involvement of Retinoic Acid Receptor-alpha -Mediated Signaling Pathway in Induction of CD38 Cell-Surface Antigen Blood, May 15, 1997; 89(10): 3607 - 3614. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Manshouri, T. Articles by Albitar, M. Search for Related Content PubMed PubMed Citation Articles by Manshouri, T. Articles by Albitar, M. Related Collections Neoplasia Social Bookmarking                   What's this?

	Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020